|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Enzon Pharmaceuticals Inc (ENZN) |
|
|
$0.09 0.00 (-2.00%) as of 4:30 Mon 5/20
|
|
Download |
|
|
|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
44,215,000 |
Market
Cap: |
4.11(M) |
Last
Volume: |
17,424 |
Avg
Vol: |
59,181 |
52
Week Range: |
$0.06 - $0.2089 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Enzon Pharmaceuticals is engaged in existing licensing arrangements with other companies primarily related to sales of certain drug products that utilize Co.'s proprietary technology. Co. has a marketing agreement relating to the drug Vicineum.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
99,550 |
99,550 |
Total Buy Value |
$0 |
$0 |
$13,910 |
$13,910 |
Total People Bought |
0 |
0 |
1 |
1 |
Total Buy Transactions |
0 |
0 |
2 |
2 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Davit Paul Stephen |
Exec. Vice Pres. HR |
|
2008-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,500 |
57,603 |
|
- |
|
Renfro Phillip M |
Director |
|
2008-05-09 |
4 |
S |
$9.45 |
$51,890 |
D/D |
(5,487) |
24 |
|
- |
|
Davit Paul Stephen |
EVP, Human Resources |
|
2008-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
50,656 |
|
- |
|
Delcampo Ralph |
EVP, Technical Operations |
|
2008-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
55,000 |
114,156 |
|
- |
|
Buchalter Jeffrey H |
Chairman, CEO & President |
|
2008-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
403,234 |
|
- |
|
Horak Ivan D |
EVP, R&D, Chief Scientific Ofc |
|
2008-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
55,000 |
91,000 |
|
- |
|
Tooman Craig A |
EVP, FINANCE, CFO |
|
2008-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
55,000 |
109,500 |
|
- |
|
Buchalter Jeffrey H |
Chairman, CEO & President |
|
2007-08-20 |
4 |
B |
$7.45 |
$37,296 |
D/D |
5,000 |
203,234 |
2.81 |
- |
|
Highbridge Convertible Arbitrage Master Fund, L.p. |
10% Owner |
|
2007-08-13 |
4 |
D |
$6.46 |
$665,636 |
I/I |
(102,343) |
0 |
|
- |
|
Highbridge Convertible Arbitrage Master Fund, L.p. |
10% Owner |
|
2007-08-13 |
4 |
B |
$6.49 |
$650,500 |
I/I |
100,000 |
50,000 |
1.5 |
- |
|
Highbridge Convertible Arbitrage Master Fund, L.p. |
10% Owner |
|
2007-08-13 |
4 |
B |
$6.46 |
$15,136 |
I/I |
2,343 |
2,343 |
1.5 |
- |
|
Highbridge Convertible Arbitrage Master Fund, L.p. |
10% Owner |
|
2007-08-02 |
4 |
D |
$7.21 |
$432,600 |
I/I |
(60,000) |
0 |
|
- |
|
Highbridge Convertible Arbitrage Master Fund, L.p. |
10% Owner |
|
2007-08-02 |
4 |
B |
$7.21 |
$432,600 |
I/I |
60,000 |
60,000 |
1.5 |
- |
|
Highbridge Convertible Arbitrage Master Fund, L.p. |
10% Owner |
|
2007-07-24 |
4 |
D |
$7.71 |
$424,050 |
I/I |
(55,000) |
0 |
|
- |
|
Highbridge Convertible Arbitrage Master Fund, L.p. |
10% Owner |
|
2007-07-24 |
4 |
B |
$7.71 |
$424,050 |
I/I |
55,000 |
55,000 |
1.5 |
- |
|
Highbridge Convertible Arbitrage Master Fund, L.p. |
10% Owner |
|
2007-07-16 |
4 |
D |
$7.75 |
$171,988 |
I/I |
(22,192) |
0 |
|
- |
|
Highbridge Convertible Arbitrage Master Fund, L.p. |
10% Owner |
|
2007-07-16 |
4 |
B |
$7.75 |
$171,988 |
I/I |
22,192 |
22,192 |
1.5 |
- |
|
Highbridge Convertible Arbitrage Master Fund, L.p. |
10% Owner |
|
2007-07-12 |
4 |
D |
$7.71 |
$3,855 |
I/I |
(500) |
0 |
|
- |
|
Highbridge Convertible Arbitrage Master Fund, L.p. |
10% Owner |
|
2007-07-12 |
4 |
B |
$7.71 |
$3,855 |
I/I |
500 |
500 |
1.42 |
- |
|
Highbridge Convertible Arbitrage Master Fund, L.p. |
10% Owner |
|
2007-07-11 |
4 |
D |
$7.73 |
$417,520 |
I/I |
(54,013) |
0 |
|
- |
|
Highbridge Convertible Arbitrage Master Fund, L.p. |
10% Owner |
|
2007-07-11 |
4 |
B |
$7.73 |
$417,520 |
I/I |
54,013 |
54,013 |
1.5 |
- |
|
Lebuhn Robert |
Director |
|
2007-07-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,105 |
86,075 |
|
- |
|
Ando Goran |
Director |
|
2007-07-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,105 |
5,181 |
|
- |
|
Micati Victor P |
Director |
|
2007-07-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,105 |
5,181 |
|
- |
|
Salisbury Robert C |
Director |
|
2007-07-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,105 |
9,212 |
|
- |
|
394 Records found
|
|
Page 13 of 16 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|